Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Virologically Controlled”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05631093
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 553
Large-scale testing (Phase 3)Active Not RecruitingNCT06333808
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With Biktarvy

Who this might be right for
HIV-1-infection
Gilead Sciences 577
Post-approval studies (Phase 4)Study completedNCT00358696
What this trial is testing

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Who this might be right for
HIVHIV Infections
University of British Columbia 30
Testing effectiveness (Phase 2)Study completedNCT00111280
What this trial is testing

TMC125-C211: Trial of TMC125 in HIV-1 Infected Subjects Who Were in a Sponsor Selected TMC125 Trial

Who this might be right for
HIV Infection
Tibotec Pharmaceuticals, Ireland 48
Not applicableLooking for participantsNCT07226128
What this trial is testing

The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIV

Who this might be right for
HIVDepression in AdultsInsulin Resistance+1 more
Indiana University 150
Post-approval studies (Phase 4)Study completedNCT02042001
What this trial is testing

Switching From Efavirenz/Atripla to Rilpivirine Among Patients With Neurocognitive or Neuropsychological Side Effects

Who this might be right for
Impaired CognitionDepression/AnxietyPoor Quality Sleep+2 more
Azienda Ospedaliera San Gerardo di Monza 74
Large-scale testing (Phase 3)Active Not RecruitingNCT06630286
What this trial is testing

Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 609
Post-approval studies (Phase 4)Study completedNCT04442737
What this trial is testing

Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Evaluated as a Fixed Dose Combination Regimen in Participants Switching From an Integrase Inhibitor Who Have Experienced Rapid Weight Gain

Who this might be right for
HIV-1
Janssen Scientific Affairs, LLC 103
Not applicableStudy completedNCT02309372
What this trial is testing

Depression Therapy to Improve Cardiovascular Risk in HIV

Who this might be right for
DepressionHIV
Indiana University 54
Testing effectiveness (Phase 2)Active Not RecruitingNCT06891066
What this trial is testing

Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)

Who this might be right for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Merck Sharp & Dohme LLC 150
Early research (Phase 1)Study completedNCT03038113
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of RO7062931in Healthy Volunteers and Subjects With Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Hoffmann-La Roche 119
Early research (Phase 1)Study completedNCT01590654
What this trial is testing

A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Gilead Sciences 51
Testing effectiveness (Phase 2)Study completedNCT04129554
What this trial is testing

JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Janssen Sciences Ireland UC 130
Large-scale testing (Phase 3)Active Not RecruitingNCT05630755
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-052)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 514
Large-scale testing (Phase 3)Active Not RecruitingNCT05502341
What this trial is testing

Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen

Who this might be right for
HIV-1-infection
Gilead Sciences 689
Testing effectiveness (Phase 2)UnknownNCT02390466
What this trial is testing

Open-label, Phase I/IIa Study of VAC-3S in HIV-1 Patients Who Showed an Immune Response to VAC-3S During IVVAC-3S/P1

Who this might be right for
HIV
InnaVirVax 15
Large-scale testing (Phase 3)Study completedNCT04223791
What this trial is testing

Switch to Doravirine/Islatravir (DOR/ISL) in Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) (MK-8591A-018)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 643
Testing effectiveness (Phase 2)Looking for participantsNCT07645287
What this trial is testing

GS-3242 in Combination With Lenacapavir Versus Biktarvy in Virologically Suppressed People With HIV-1

Who this might be right for
HIV-1-infection
Gilead Sciences 175
Testing effectiveness (Phase 2)Study completedNCT05306249
What this trial is testing

Effects of Cannabidiol (CBD) on the Activation of Autophagy and Inflammation Genes, Functional Consequences in Virologically Controlled HIV-infected Patients

Who this might be right for
HIV Seropositivity
Centre Hospitalier Régional d'Orléans 80
Testing effectiveness (Phase 2)Study completedNCT04564547
What this trial is testing

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 161
Next Page